Accessible, Cutting-Edge, Transformative Cellular Therapies
ImmunoACT:

India’s 1st Indigenous CAR-T Cell Therapy

Impact of NexCAR 19

90%

Remission Rate

200+

Patients Treated

2x

Likely To Stay Cancer-free

2yrs

Longest Remission Rate

CAR-T Cell Therapy

Harnessing Your Immune System to Fight Cancer Safely

India faces a growing cancer burden, ranking second globally in cancer mortality. For aggressive B-cell malignancies like Acute Lymphoblastic Leukemia (blood cancer) and Large B-cell Lymphoma (lymph node cancer), over 40% of patients relapse or resist chemotherapy and other standard treatments.

ImmunoACT brings revolutionary CAR-T cell therapy for cancer treatment in India, where a patient’s own immune cells are genetically modified to recognize and destroy cancer cells. This groundbreaking approach has demonstrated remarkable improvements in overall survival and offers new hope for patients seeking advanced CAR-T therapy in India with limited treatment options.

Real Stories of Hope

At ImmunoACT, we believe that every patient story matters. Our CAR-T cell therapies are transforming lives-bringing hope where options were once limited. These powerful testimonials reflect not only the resilience of our patients but also the impact of cutting-edge, gene-modified cell therapy. As we work alongside leading healthcare institutions, academic collaborators, and strategic partners, our mission remains clear: to expand equitable access to advanced immunotherapies and redefine cancer care in India and beyond.

Our Manufacturing Facility

At ImmunoACT, our advanced manufacturing facility is purpose-built to deliver high-quality, safe, and scalable cell and gene therapies. With the capacity to treat up to 750 patients annually, we ensure timely and consistent access to life-saving treatments.

  • WHO-Certified GMP Facility: Compliant with global quality and safety standards to ensure purity, consistency, and efficacy in every therapy.
  • Scalable Treatment Capacity: Expanding from 750 to 1,500 patients per year to meet growing demand and reduce treatment wait times.
  • End-to-End Manufacturing: Fully integrated process from plasmid design to viral vector production and ex-VIVO cell engineering.
  • Rapid & Reliable Delivery: Streamlined operations for fast turnaround, ensuring therapies reach patients when they need them most.
  • Global-Standard Quality Control: Dedicated QC/QA units to rigorously test and validate each batch before release.
  • Clinician-Centric Support: Backed by experts in clinical trials, regulatory affairs, and treatment logistics to simplify doctor workflows.
  • Patient-Focused Outcomes: Facility designed with one goal in mind: enabling safe, accessible, and effective therapies for every patient

What is NexCAR19™ ?

NexCAR19™ is a CAR-T cell therapy that involves the genetic modification of  your T-cells in a lab, empowering them to identify and destroy specific cancerous B-cells upon re-introduction into the body.

NexCAR19™’s Impact 

Total Patients Treated

200+

Lives transformed through treatment

B-NHL Remission Rate

68%

at 3 months in clinical trials

B-ALL Rate

73%

at 3 months in clinical trials

Vein-To-Vein Time

~20

days in Clinical Trials

Longest Remission

2+

years of sustained response

Partnered Hospitals

Our strong association with over 80 leading cancer treatment hospitals in India ensures hassle-free treatment with our CAR-T cell therapies.

Find A Treatment Centre Near You

Strategic Collaborations

To advance the research and development of our innovative gene-modified cell therapies, we are fostering relationships across academia, healthcare institutions, and strategic partnerships with the intent to equitize access.

Stories of Hope

Ramnath Vishnu

Cancer Survivor

After years of setbacks with traditional treatments, CAR-T cell therapy changed everything. The idea of using my own cells to fight the cancer gave me hope. Now, I’m in remission, and I feel like I’ve truly gotten my life back. I can finally look forward to the future without fear.

Ramnath Vishnu

Cancer Survivor

After years of setbacks with traditional treatments, CAR-T cell therapy changed everything. The idea of using my own cells to fight the cancer gave me hope. Now, I’m in remission, and I feel like I’ve truly gotten my life back. I can finally look forward to the future without fear.

Ramnath Vishnu

Cancer Survivor

After years of setbacks with traditional treatments, CAR-T cell therapy changed everything. The idea of using my own cells to fight the cancer gave me hope. Now, I’m in remission, and I feel like I’ve truly gotten my life back. I can finally look forward to the future without fear.

Real Stories of Hope

Ramnath Vishnu

Cancer Survivor

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer leo enim, fringilla sit amet massa vitae, faucibus consectetur neque…

Ramnath Vishnu

Cancer Survivor

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer leo enim, fringilla sit amet massa vitae, faucibus consectetur neque…

Ramnath Vishnu

Cancer Survivor

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer leo enim, fringilla sit amet massa vitae, faucibus consectetur neque…

Frequently Asked Questions

View All FAQs

Harnessing Your Immune System to Fight Cancer Safely

Begin Your Personalized Cancer Treatment Journey

Discuss Treatment Options

Frequently Asked Questions

View All FAQs
Let's Get in Touch with
ImmunoACT Logo